Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals.

Arnaiz JA, Carné X, Riba N, Codina C, Ribas J, Trilla A.

Eur J Clin Pharmacol. 2001 Apr;57(1):89-91. Review.

PMID:
11372600
2.

The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.

Olivier P, Montastruc JL.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):808-12.

PMID:
16700082
3.

Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?

Paludetto MN, Olivier-Abbal P, Montastruc JL.

Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1289-94. doi: 10.1002/pds.3333. Epub 2012 Sep 7.

PMID:
22961933
4.

Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.

Shalviri G, Mohammad K, Majdzadeh R, Gholami K.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1136-40.

PMID:
17705214
5.

New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.

Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S.

Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):229-37.

PMID:
17063533
6.

[Reporting of adverse drug reactions in Iceland in 1999 to 2004].

Jóhannsson M, Agústsdóttir E.

Laeknabladid. 2006 Apr;92(4):283-7. Icelandic.

PMID:
16582456
7.

Spontaneous reporting of adverse drug reactions by nurses.

Bäckström M, Mjörndal T, Dahlqvist R.

Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):647-50. Erratum in: Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):157-9.

PMID:
12512239
8.
9.

Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.

Durrieu G, Olivier P, Bagheri H, Montastruc JL; French Network of Pharmacovigilance Centers.

Fundam Clin Pharmacol. 2007 Oct;21(5):555-8.

PMID:
17868209
10.

Reporting of fatal adverse drug reactions.

Liu BA, Knowles SR, Mittmann N, Einarson T, Shear NH.

Can J Clin Pharmacol. 2001 Summer;8(2):84-8. English, French.

PMID:
11493936
11.

Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.

Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL.

J Clin Oncol. 2003 Oct 15;21(20):3859-66. Erratum in: J Clin Oncol. 2004 Mar 15;22(6):1169.

PMID:
14551305
12.

Database size and power to detect safety signals in pharmacovigilance.

Hammond IW, Gibbs TG, Seifert HA, Rich DS.

Expert Opin Drug Saf. 2007 Nov;6(6):713-21. Review.

PMID:
17967160
13.

On the clinical evidence leading to tetrazepam withdrawal.

Proy-Vega B, Aguirre C, de Groot P, Solís-García del Pozo J, Jordán J.

Expert Opin Drug Saf. 2014 Jun;13(6):705-12. doi: 10.1517/14740338.2014.915023. Review.

PMID:
24845943
14.

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

Poluzzi E, Raschi E, Moretti U, De Ponti F.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):512-8. doi: 10.1002/pds.1746.

PMID:
19358226
15.

Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector?

Aagaard L, Soendergaard B, Stenver DI, Hansen EH.

Br J Clin Pharmacol. 2008 Mar;65(3):364-76. Epub 2007 Oct 24.

17.

Adverse drug reactions of psycopharmacs.

Skvrce NM, Arapović S, Krnić D, Sarinić VM, Zezelić S, Bagatin K, Leventić J, Tomić S.

Psychiatr Danub. 2010 Sep;22(3):441-5.

18.

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.

Onakpoya IJ, Heneghan CJ, Aronson JK.

BMC Med. 2016 Feb 4;14:10. doi: 10.1186/s12916-016-0553-2. Review.

19.

Adverse drug reactions to anthelmintics.

Bagheri H, Simiand E, Montastruc JL, Magnaval JF.

Ann Pharmacother. 2004 Mar;38(3):383-8. Epub 2004 Jan 23.

PMID:
14749518
20.

[Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].

Montastruc JL, Lugardon S, Desboeuf K, Fernet P, Lapeyre-Mestre M.

Bull Acad Natl Med. 2008 Feb;192(2):421-30; discussion 430-1. French.

PMID:
18819693

Supplemental Content

Support Center